Sanmina Corp. Hits New 52-Week High of $230.00, Soars 224.78%

Sanmina Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by hitting a new 52-week high of USD 230.00 on April 28, 2026. This achievement underscores the company's impressive performance over the past year, with a remarkable increase of 224.78%, significantly outpacing the S&P 500's growth of 29.12% during the same period. With a market capitalization of USD 12,249 million, Sanmina Corp. operates with a price-to-earnings (P/E) ratio of 39.00, reflecting its valuation in the market. The company maintains a debt-to-equity ratio of 0.31, indicating a relatively low level of debt compared to its equity. Additionally, Sanmina Corp. has a return on equity of 12.64%, showcasing its ability to generate profits from shareholders' equity. Despite not offering a dividend, the stock's performance and financial metrics highlight its position within the industry, marking a noteworthy moment for investors and stakeholders alike.